From the news

Recent transaction and litigation

Publications

February / 2014

Representation of ADSs by Mazor Robotics Ltd.

Our firm represented Barclays and several other underwriters in the $41 million initial public offering of ADSs by Mazor Robotics Ltd. on NASDAQ.

January / 2014

Representation of Conduit

Meitar represented Conduit in its spin-off of ClientConnect, Conduit’s toolbar division, and the subsequent purchase of ClientConnect by Perion Network Ltd., a NASDAQ company, in an all stock transaction. Conduit’s shareholders and option holders received 81% of Perion shares in the transaction, which closed in January 2014.

January / 2014

Representation of Covidien in its acquisition of Given Imaging for approximately $1 billion

Meitar represented NYSE-listed Covidien, a US medical device manufacture, in its acquisition of Given Imaging, a medical technology company that develops and manufactures the swallowable imaging capsules for endoscopy, for approximately $1 billion.

November / 2012

Advising Cisco in its Acquisition of Intucell

Meitar acted as local counsel for Cisco in its acquisition of Intucell an advanced self-optimizing network (SON) software privately held Israeli company.

November / 2012

Hypertoy Wins a Trademark Infringement Action

Meitar successfully represented Hypertoy in a legal action and a motion for a preliminary injunction relating to infringement of the trademark “TOY PLANET”, leading to the cessation of all infringing activities.

November / 2012

Representation of Nolio in its acquisition by CA Technologies

Meitar represented Israeli app deployment and management company Nolio in its acquisition by IT software giant CA Technologies.

November / 2012

Representation of Enzymotec in its initial public offering on NASDAQ

Meitar represented Enzymotec Ltd., a developer of lipid-based products and solutions for the nutritional and healthcare markets, in its initial public offering on NASDAQ raising approximately $70M (including exercise at closing of the underwriters’ overallotment option in full). Bank of America Merrill Lynch and Jefferies LLC acted as joint book-running managers for the offering.